← Leaderboards
Grant D Trobridge
Fred Hutchinson Cancer Research Center
$4,800,260
Attributed
$4,800,260
Total exposure
5
Grants
5
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $1.1M · FY2006–17$2M$1.5M$1M$500K$0
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
Funding mix
By agency
NIH$4,800,260 · 5
By mechanism
R01$1,832,626 · 1
P01$1,572,134 · 1
R21$977,682 · 2
R15$417,818 · 1
Top collaborators
No co-investigators on record.
Most similar at Fred Hutchinson Cancer Research Center
Same institution · by research overlap
- Brian C Beard$2,776,222
- George Earl Georges$15,152,269
- Robert Nash$887,415
- Rainer F. Storb$23,835,935
- Derek L Stirewalt$11,495,563
Others in their field
Top investigators on “Vector”
- Lawrence Corey · Fred Hutchinson Cancer Center$446,547,761
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$239,426,049
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$142,420,923
- David Heimbrook · Leidos Biomedical Research, Inc.$141,066,079
- Peter B. Gilbert · Fred Hutchinson Cancer Center$124,296,230
- Philip Goode · New Jersey Institute Of Technology$73,697,028
Research focus
VectorCellsBaseSafetyHematopoietic Stem CellsSpumavirusGenesGene TherapyIn VitroIn VivoLeukemiaLentivirus VectorProto-OncogenesPlasmidsClinical TrialsTransgene ExpressionShuttle VectorsMouse ModelClonal ExpansionRelative (Related Person)FutureGenerationsDesignProduction
Grant awards (17)
Improved Foamy Virus Vectors for AIDS Gene Therapy$370,977
R01 · FY2017 · AI · contact PI
Improved Foamy Virus Vectors for AIDS Gene Therapy$370,977
R01 · FY2016 · AI · contact PI
Second Generation Approaches to Foamy Virus (FV) Vector SCID-X1 Gene Therapy$301,315
P01 · FY2016 · AI · contact PI
Improved Foamy Virus Vectors for AIDS Gene Therapy$370,977
R01 · FY2015 · AI · contact PI
Second Generation Approaches to Foamy Virus (FV) Vector SCID-X1 Gene Therapy$301,543
P01 · FY2015 · AI · contact PI
Improved Foamy Virus Vectors for AIDS Gene Therapy$370,977
R01 · FY2014 · AI · contact PI
Second Generation Approaches to Foamy Virus (FV) Vector SCID-X1 Gene Therapy$286,667
P01 · FY2014 · AI · contact PI
Mutagenesis Screen for Prostate Cancer$417,818
R15 · FY2013 · CA · contact PI
Improved Foamy Virus Vectors for AIDS Gene Therapy$348,718
R01 · FY2013 · AI · contact PI
Second Generation Approaches to Foamy Virus (FV) Vector SCID-X1 Gene Therapy$317,415
P01 · FY2013 · AI · contact PI
Second Generation Approaches to Foamy Virus (FV) Vector SCID-X1 Gene Therapy$365,194
P01 · FY2012 · AI · contact PI
Stem Cell Gene Therapy for Pyruvate Kinase Deficiency Using Foamy Vectors$162,788
R21 · FY2009 · DK · contact PI
Stem Cell Gene Therapy for Pyruvate Kinase Deficiency Using Foamy Vectors$71,863
R21 · FY2009 · DK · contact PI
Stem Cell Gene Therapy for Pyruvate Kinase Deficiency Using Foamy Vectors$11,556
R21 · FY2009 · DK · contact PI
Stem Cell Gene Therapy for Pyruvate Kinase Deficiency Using Foamy Vectors$220,000
R21 · FY2008 · DK · contact PI
Efficacy and Safety of Foamy Retroviral Vectors for AIDS Gene Therapy$251,975
R21 · FY2007 · AI · contact PI
Efficacy and Safety of Foamy Retroviral Vectors for AIDS Gene Therapy$259,500
R21 · FY2006 · AI · contact PI